Suppr超能文献

慢性收缩性心力衰竭患者的血清氧化应激水平与临床参数相关。

Serum oxidative stress level correlates with clinical parameters in chronic systolic heart failure patients.

作者信息

Amir Offer, Paz Hagar, Rogowski Ori, Barshai Marina, Sagiv Moran, Shnizer Sergei, Reznick Abraham Z, Amir Ruthie E

机构信息

Department of Cardiology, Lady Davis Carmel Medical Center, Haifa, Israel.

出版信息

Clin Cardiol. 2009 Apr;32(4):199-203. doi: 10.1002/clc.20317.

Abstract

BACKGROUND

Serum oxidative stress (OS) level has an important role in the inflammatory process of heart failure.

HYPOTHESIS

The study was designed to analyze serum OS levels in chronic heart failure (HF) patients and to examine the relation between OS levels and other clinical and prognostic parameters of HF.

METHODS

We studied 82 consecutive chronic symptomatic HF patients with systolic LV dysfunction (ejection fraction <45%). The serum OS level was determined using thermochemiluminescence assay. We compared the serum OS levels with patients' clinical and prognostic parameters.

RESULTS

Higher serum OS levels were associated with higher New York Heart Association class (P = .01), worse renal function (serum urea, creatinine, and creatinine clearance) (P<.001) and higher serum levels of hs-C-reactive protein and N-terminal pro brain natriuretic peptide (P = .001, P<.001, respectively).

CONCLUSIONS

In chronic systolic HF patients, high serum OS levels correlate with advanced disease and known markers of poor prognosis.

摘要

背景

血清氧化应激(OS)水平在心力衰竭的炎症过程中起重要作用。

假设

本研究旨在分析慢性心力衰竭(HF)患者的血清OS水平,并探讨OS水平与HF的其他临床及预后参数之间的关系。

方法

我们研究了82例连续的有症状的慢性收缩性HF患者,其左心室功能不全(射血分数<45%)。采用热化学发光分析法测定血清OS水平。我们将血清OS水平与患者的临床及预后参数进行了比较。

结果

较高的血清OS水平与较高的纽约心脏协会分级相关(P = 0.01),肾功能较差(血清尿素、肌酐和肌酐清除率)(P<0.001)以及较高的血清高敏C反应蛋白和N末端脑钠肽前体水平相关(分别为P = 0.001,P<0.001)。

结论

在慢性收缩性HF患者中,高血清OS水平与疾病进展及已知的不良预后标志物相关。

相似文献

3
Neopterin as a novel marker; well correlated with mortality and morbidity in patients with advanced systolic heart failure.
Acta Cardiol. 2019 Jun;74(3):216-221. doi: 10.1080/00015385.2018.1478266. Epub 2018 Jun 18.
4
NT-pro-BNP predicts worsening renal function in patients with chronic systolic heart failure.
Intern Med J. 2011 Jun;41(6):467-72. doi: 10.1111/j.1445-5994.2010.02203.x. Epub 2010 Feb 26.
5
Biomarker-assist score for reverse remodeling prediction in heart failure: The ST2-R2 score.
Int J Cardiol. 2015 Apr 1;184:337-343. doi: 10.1016/j.ijcard.2015.02.019. Epub 2015 Feb 17.
7
Albumin levels predict survival in patients with systolic heart failure.
Am Heart J. 2008 May;155(5):883-9. doi: 10.1016/j.ahj.2007.11.043. Epub 2008 Jan 30.
8
Atrial fibrillation and amino-terminal pro-brain natriuretic peptide as independent predictors of prognosis in systolic heart failure.
Int J Cardiol. 2010 Apr 30;140(3):344-50. doi: 10.1016/j.ijcard.2008.11.108. Epub 2009 Jan 6.
9
Incremental prognostic value of assessing left ventricular myocardial mechanics in patients with chronic systolic heart failure.
J Am Coll Cardiol. 2012 Nov 13;60(20):2074-81. doi: 10.1016/j.jacc.2012.07.047. Epub 2012 Oct 17.
10
Phenotyping progression of secondary mitral regurgitation in chronic systolic heart failure.
Eur J Clin Invest. 2019 Nov;49(11):e13159. doi: 10.1111/eci.13159. Epub 2019 Oct 9.

引用本文的文献

1
Malondialdehyde and Uric Acid as Predictors of Adverse Outcome in Patients with Chronic Heart Failure.
Oxid Med Cell Longev. 2019 Oct 9;2019:9246138. doi: 10.1155/2019/9246138. eCollection 2019.
5
Oxidative stress and inflammatory markers - the future of heart failure diagnostics?
Kardiochir Torakochirurgia Pol. 2015 Jun;12(2):145-9. doi: 10.5114/kitp.2015.52856. Epub 2015 Jun 30.
6
Changes in the monocytic subsets CD14(dim)CD16(+) and CD14(++)CD16(-) in chronic systolic heart failure patients.
Mediators Inflamm. 2012;2012:616384. doi: 10.1155/2012/616384. Epub 2012 Nov 27.

本文引用的文献

3
A randomized clinical trial of trimetazidine, a partial free fatty acid oxidation inhibitor, in patients with heart failure.
J Am Coll Cardiol. 2006 Sep 5;48(5):992-8. doi: 10.1016/j.jacc.2006.03.060. Epub 2006 Aug 17.
4
Mitochondrial oxidative stress and heart failure.
Intern Med. 2006;45(13):809-13. doi: 10.2169/internalmedicine.45.1765. Epub 2006 Aug 1.
5
Reduction of inflammatory cytokine expression and oxidative damage by erythropoietin in chronic heart failure.
Cardiovasc Res. 2006 Sep 1;71(4):684-94. doi: 10.1016/j.cardiores.2006.06.003. Epub 2006 Jun 6.
6
In renal transplanted patients inflammation and oxidative stress are interrelated.
Transplant Proc. 2006 May;38(4):1026-30. doi: 10.1016/j.transproceed.2006.02.009.
7
Biomarkers of oxidative damage in human disease.
Clin Chem. 2006 Apr;52(4):601-23. doi: 10.1373/clinchem.2005.061408. Epub 2006 Feb 16.
8
Renal function as a predictor of outcome in a broad spectrum of patients with heart failure.
Circulation. 2006 Feb 7;113(5):671-8. doi: 10.1161/CIRCULATIONAHA.105.580506.
10
DNA oxidative damage in patients with dialysis treatment.
Ren Fail. 2005;27(6):689-94. doi: 10.1080/08860220500242678.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验